Birth ofthe British National Formulary
When the war ended it was the two non-govemmental bodies that had been most closely associated with the National War Formulary, the Pharmaceutical Society of Great Britain and the British Medical Association, which wanted to continue publication of a formulary for general use. Thus the British National Formulary was bom a direct descendant of the war formulary.
The first edition was published in 1949, and new editions appeared thereafter about every three years until 1976. When I was appointed a member of the Joint Formulary Committee in 1963, I did not know that I was to hold that appointment for 21 years.
It was an enormous committee with 38 members, doctors and pharmacists. Most Belfast; all of us were to become close friends.
Much of the time of the committee was spent in deciding which drugs and preparations were to be selected for inclusion in the formulary. The general practitioner members were mostly elderly and very conservative in their views, and they tended to resent any changes in the formulary. There was much prolonged and detailed discussion, sometimes heated, about the notes for prescribers, which came at the beginning of the book and at the beginning of each section about different groups of drugs-alimentary, cardiovascular, anti-infective, etc. The usual procedure was for a member of the committee, usually one of the academic members, to be asked to produce a draft of one of the sections, and this was then discussed and modified in committee. It was a slow and often tedious business. The meetings were held in a large and gloomy committee room at BMA House in Tavistock Square. They started at I0 am and seldom finished before 4 or 5 pm. I often had difficulty in getting to Euston, only a few hundred yards away, in time to get the boat train to Liverpool at 4-55 pm or to Heysham at 5.40 pm.
By the time I joined the committee English had already replaced Latin in the British National Formulary, and the old apothecaries' system of grains and minims was being replaced with what some members thought was the new fangled metric system. Monographs on new and important drugs such as the penicillins, tetracyclines, and corticosteroids had been included in the formulary, but there were still a lot of traditional tonics and mixtures. I remember very vividly dear old Dr Leak of Lee in Staffordshire, who always fought a strong rearguard action to prevent us deleting any of them. I admired Andrew Wilson; he was extremely tolerant and patient and very skilled at calming tempers, and I leamt a lot on how to handle difficult meetings by watching him.
Over the next 14 years I was asked at one time or another to put my hand to drafting almost every section of the formulary: drug dependence, prescribing for the elderly, adverse reactions to drugs, notes on drugs for the alimentary, cardiovascular, respiratory, and nervous systems and for infectious diseases and on vaccines. It was rather like undertaking a continuous comprehensive refresher course, and it helped me in my teaching both to undergraduates and to general practitioners as I felt confident that I was fully conversant with current thinking and practice.
The constitution of the Joint Formulary Committee was modified in 1969; it became smaller and a number of younger and well informed people were appointed. The preparation of the monographs was a much heavier task than the preparation of the notes for prescribers and presented us with great difficulties. There was always a great deal of information available for every preparation, but we were producing a handbook and we needed to confine the entry for each preparation to the information that doctors actually needed in order to make a decision when treating a patient.
In was included concerning the written instructions which were to be given to patients when their medicines were dispensed by their pharmacist. After a battle with the Department of Health and Social Security and much encouragement from my wife, who is a dentist, a version of the formulary was prepared every two years for dental surgeons and is much appreciated by them.
It was a problem to keep the British National Formulary as a handbook. There were always requests that i-nformation should be included which was more appropriate for a textbook than for a handbook. There were continued arguments about the best way to indicate the cost of drugs. The committee believed that doctors needed to be able to compare the price of preparations that are used for similar purposes, such as the many tranquillisers, analgesics, or diuretics that are available. For this purpose we gave the cost of 20 tablets of each preparation. But we had to admit that this might be misleading, for it is difficult to compare the cost of ordinary tablets of a drug with that of slow release tablets which, although much more expensive, only require one to be taken each day. Some people asked that we should give the cost of a week's treatment with the various preparations, although the problem of doing this is that the dosage for different patients would differ, and any average dosage which we might use in calculating the weekly cost would be rather arbitrary. We felt it was better to keep to the present system, the accuracy ofwhich cannot be questioned.
Conclusion
This rebirth of the Bnitish National Formulary was a wonderful example of what a small team can achieve, and it showed how effectively doctors and pharmacists can work together. I like to think that we went a little way along the road to heal a breach between the two professions, which, in one way or another, has existed since 1518, when the physicians separated themselves from the apothecaries and Dr Linacre, physician to Henry VIII, founded the Royal College of Physicians.
The members of the Joint Formulary Committee met initially as professionals but, as we worked together, we developed deep mutual respect and close personal friendships. We all felt that we were superbly served by the editorial staff, led first by the late Ron Brown and then by Anne Prasad, both of them totally professional and dedicated to the formulary. We felt that we were doing something really useful for our professions and through them for patients, and we were happy in our work. Would that other committees were as worth while to sit on.
I retired in 1984 after the 12th edition. The 25th edition may not have increased much in girth, but I think everyone will agree that it has grown in stature. I wish it well for its next 25 issues. BMJ 1993; 306:1054-6 The low concentration of hepatitis C virus in the blood of infected patients has made it difficult to detect. Infected patients can now be identified by using more sensitive immunoassays and amplification ofviral RNA by the polymerase chain reaction. Nevertheless, the virus remains difficult to eliminate. We present the case of a woman with a history of autoimmune haemolytic anaemia, thrombocytopenia, and common variable immunodeficiency who developed chronic hepatitis.
Case history
A 36 year old woman was admitted to this hospital for investigation of abnormal liver function tests results in March 1991. In 1979 she had felt tired and unwell and was found to have a haemoglobin concentration of 28g/l with a Coombs' positive autoimmune haemolytic anaemia. This was treated with steroids and a blood transfusion. She recovered well and has subsequently had negative results on the Coombs' test. In 1983, however, she developed idiopathic thrombocytopenic purpura, requiring platelet transfusions and a splenectomy. Later that year she developed recurrent chest infections, and investigations showed panhypogammaglobulinaemia due to common variable immunodeficiency. This was treated successfully with immunoglobulin injections, and later with monthly immunoglobulin infusions.
In 1986 the thrombocytopenia recurred and she was treated with platelet transfusions, steroids, and azathioprine. The following year she developed jaundice, pale stools, and dark urine in addition to a pancytopenia. Azathioprine was stopped, and she required further blood transfusions. The jaundice cleared in six weeks, but during 1987-91 she continued to experience malaise and anorexia, with fluctuating liver function abnormalities.
Examination showed mild jaundice, palmar erythema, and spider naevi but no hepatic encephalopathy. Chest examination showed symptoms consistent with mild bronchiectasis. Her liver was of normal size and not tender.
Investigations included a full blood count and coagulation screen, which gave normal results. She had a low total protein concentration (51 g/l) but a normal albumin concentration (38 g/l). She was panhypogammaglobulinaemic (IgG 4-6 (normal range 5-16), IgA <0 07 (1-25-4.25), IgM 0-08 (0-5-1-8) g/l). Her bilirubin concentration was 76 ,umol (<17), aspartate aminotransferase 209 (< 35) IUll, alkaline phosphatase 414 (< 125) IU/1, and y-glutamyl transferase 414 (< 30) IU/1.
Importantly, an autoantibody screen, including antibodies to smooth muscle and nuclear bodies, gave negative results. Her serum was tested and found negative for antibodies to hepatitis A IgM, hepatitis B surface antigen and core antibody, hepatitis C antibody (first generation test), infectious mononucleosis, and cytomegalovirus antibody. Ferritin and copper studies gave normal results and her thyroid function was normal.
A liver biopsy showed normal vascular relations, with some focal necrosis and compensatory hyerplasia. Portal tracts were infiltrated with large numbers of lymphocytes. Mild piecemeal necrosis was present. These features suggested chronic active hepatitis without cirrhosis (fig 1) .
The differential diagnosis included autoimmune chronic active hepatitis as well as viral hepatitis. Autoimmune chronic active hepatitis would have been consistent with the patient's age, sex, and autoimmune history, and the negative autoantibody tests could have resulted from the hypogammaglobulinaemia. Likewise, viral hepatitis acquired from the multiple blood product transfusions she had received was also a reasonable diagnosis, and once again the low circulating
